Zusammenfassung
Es wird nur auf die Antibiotika eingegangen, die in Deutschland eine therapeutische Rolle spielen. Nicht eingegangen wird auf Mupirocin, da dieses nur in Nasensalben verwendet werden sollte, vor allem zur Bekämpfung von Methicillin resistenten Staphylococcus aureus (MRSA) Besiedelungen in der Nase. Um Resistenzinduktionen vorzubeugen, sollte eine dermatologische Behandlung unterbleiben. Nicht ausführlich besprochen wird auch Nadifloxacin, das in Japan als Spezialität zur Verfügung steht, nicht aber in Deutschland. Auch Kanamycin bleibt außer Betracht, da es in Deutschland ausschließlich in Ophthalmologica verwendet wird.
ArticleFootNote
unter Mitarbeit von J. Fluhr
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Literatur
Abeck D, Mempel M (1998) Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications. Br J Dermatol 139 Suppl 53: 13–16
Akamatsu H, Niwa Y, Kurokawa I, Masuda R, Nishijima S, Asada Y (1991a) Effects of subminimal inhibitory concentrations of minocycline on neutrophil chemotactic factor production in comedonal bacteria, neutrophil phagocytosis and oxygen metabolism. Arch Dermatol Res 283: 524–528
Akamatsu H, Nishijima S, Takahashi M, Ushijima T, Asada Y (1991b) Effects of subminimal inhibitory concentrations of erythromycin, tetracycline, clindamycin, and minocycline on the neutrophil chemotactic factor production in propionibacterium acne biotypes 1–5. J Dermatol 18: 247–251
Chu A, Huber EJ, Plott AT (1997) The comparative efficacy of benzoyl peroxide 5%/erythromycin 3% gel and erythromycin 4%/zink 1.2% solution in the treatment of acne vulgaris. Br J Dermatol 136: 235–238
Cork MJ (1996) The role of staphylococcus aureus in atopic eczema: treatment strategies. J Europ Acad Dermatol Venereol 7 Suppl 1: 31–37
Crawford WJ, Crawford IP, Stoughton RB, Cornell RC (1979) Laboratory induction and clinical occurence of combined clindamycin and erythromycin resistance in Corynebacterium acnes. J Invest Dermatol 72: 187–190
Dalziel K, Dykes PJ, Marks R (1987) The effect of tetracycline and erythromycin in a model of acne type inflammation. Br J Exp Pathol 68: 67–70
Dhar S, Kanwar AJ, Kaur S, Sharma P, Ganguly (1992) Role of bacterial flora in the pathogenesis and management of atopic dermatitis. Indian J Med Res 95: 234–238
Eady EA, Cove JH, Holland KT, Cunliffe WJ (1989) Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. Br J Dermato1 121: 51–57
Eady EA, Cove JH, Joanes DN, Cunliffe WJ (1990) Topical antibiotics for the treatment of acne vulgaris: a critical evaluation of the literature on their clinical benefit and comparative efficacy. J Dermatol Treatm 1: 215–226
Eady EA, Ingham E, Walters CE, Cove JH, Cunliffe WJ (1993). Acne patients treated with tetracyclines. J Invest Dermatol l00: 86–91
Eady EA, Jones CE, Vyakrnam S, Cove JH, Cunliffe WJ (1997) Increasing prevalence of antibiotic resistant propionibacteria on the skin of acne patients: results of a five year study. Br J Dermatol 137 Suppl 50: 34
Elewki BE, Sam M jr, Gammon WR (1983) In vivo suppression of neutrophil chemotaxis by systemically and topically administered tetracycline. J Am Acad Dermatol 8: 807–812
Eller MG, Smith RB, Philips JP (1989) Absorption kinetics of topical clindamycin preparations. Biopharm Drug Disp l0: 505–512
Esser B (1987) Vergleich zwischen Zineryt (Erythromycin 4% + Zinkacetat) and Erythromycin 2% bei der topischen Behandlung der Acne vulgaris. Dtsch Dermatol 35: 297–301
Esterly NB, Koransky JS, Furey NL, Trevisan M (1984) Neutrophilic chemotaxis in patients with acne receiving oral tetracycline therapy. Arch Dermatol 120: 1308–1313
Fluhr JW, Gloor M, Merkel W, Warnecke J, Höffler U, Lehmacher W, Glutsch J (1998) Antibacterial and sebosuppressive efficacy of a combination of chloramphenicol and pale sulfonated shale oil. Arzneimittelforschung 48: 188–196
Fluhr JW, Gloor M, Dietz P, Höffler U (1999a) In vitro activity of 6 antimicrobials against propionibacteria isolates from untreated acne papulopustulosa. Zentralbi Bakteriol 289: 53–61
Fluhr JW, Bösch B, Gloor M, Höffler U (1999b) Efficacy of zinc acetate alone and in combination with erythromycin against propionibacteria in vitro and in vivo. Zentralbi Bakteriol 289: 445–456
Forssmann Th, Gloor M, Gehring W (1994) Antibiotikaresistenzen bei Acne vulgaris - Eine retrospektive Untersuchung an einem antibiotisch vorbehandelten and einem unbehandelten Kollektiv. Z Hautkr 69: 828–832
Gardner KJ, Cunliffe WJ, Eady EA, Cove JH (1994) Variation in comedonal antibiotic concentra-tions following application of topical tetracycline for acne vulgaris. Br J Dermato 1131: 649–654
Gehring W, Forssmann Th, Jost G, Gloor M (1996) Die keimreduzierende Wirkung von Erythro-mycin and Triclosan bei der atopischen Dermatitis. Akt Dermatol 22: 28–31
Gloor M, Bauer W (1979) Die Gesichtsmaske als Grundlage der externen Klindamycintherapie der Acne vulgaris. Hautarzt 30: 380–383
Gloor M, Kraft H, Franke M (1978) Effectiveness of topically applied antibiotics on anaerobic bacteria in the pilo-sebaceous duct. Dermatologica 157: 96–104
Gloor M, Pfahler E, Neumann W, Höffler U, Hoffmann M, Schmid U (1982a) Lokale Aknetherapie mit Erythromycin and Benzoylperoxid. Z Hautkr 57: 867–878
Gloor M, Peters G, Stoika D (1982b) On the resident aerobic bacterial skin flora in unaffected skin of patients with atopic dermatitis and in healthy controls. Dermatologica 164: 258–265
Gollnik H, Melzer A (1997) Erythromycin and eine Erythromycin-Zink-Kombination in der to-pischen Aknetherapie. Z Dermatol 183: 8–18
Guin JD, Huber DS, Gielerac PL (1979) Antibiotic sensivity of comedonal propionibacterium acnes. Acta Derm Venereol (Stockh) 59: 552–554
Guin JD, Reynolds R, Gielerac PL (1980) Penetration of topical clindamycin into comedones. J Am Acad Dermatol 3: 153–156
Habbema L, Koopmans B, Menke HE, Doornweerd S, Boulle KD (1989) A 4% erythromycin and zinc combination (Zineryt) versus 2% erythromycin (Eryderm) in acne vulgaris: a randomized, double blind comparative study. Br J Dermatol 121: 497–502
Harkaway KS, McGinley KJ, Foglia AN, Lee WL, Fried F, Shalita AR, Leyden JJ (1992) Antibiotic resistance patterns in coagulase negative staphylocci after treatment with topical erythromycin, benzoyl peroxide, and a combination therapy. Br J Dermatol 126: 586–590
Höffler U, Gloor M, Nicolai Hy (1981) Neuraminidase production by propionibacterium acnesstrains isolated from patients with acne vulgaris, seborrhoic eczema and healthy subjects. Zentralbi Bakteriol Hyg I Abt Orig A 250: 122–126
Höger PH (1998) Topische Antibiotika-und Antiseptika-Agentien, Spektren, Nebenwirkungen. Hautarzt 49: 331–347
Hoogdalem EJ van, Terpstra IJ, Baven ALM (1996) Evaluation of the effect of zinc acetate on the stratum corneum penetration kinetics of erythromycin in healthy male volunteers. Skin Pharmacol 9: 104–110
Hoogdalem EJ van (1998) Transdermal absorption of topical anti-acne agents in man: review of clinical pharmacokinetic data. J Eur Acad Dermatol Venerol 11 Suppl 1: 13–19
Knight AG, Vickers CRH, Percival A (1969) The percutaneous absorption of antibacterial sub-stances. Br J Dermatol 84, Suppl 4: 88–91
Korting H Ch, Abeck D, Grimm W, Schiller Y (1990) Heutige in vitro Empfindlichkeit von Hautbakterien gegenüber unterschiedlichen Chemotherapeutika. Quantitative Ergebnisse des Mikrodilutionstests. Akt Dermatol 16: 27–31
Kresken M, Hafner D (1996) Praevalenz der Antibiotikaresistenz bei klinisch wichtigen Infektionserregern in Mitteleuropa. Chemother 5: 225–230
Kurokawa I, Nishijima S, Asada Y (1988) The antibiotic susceptibility of propionibacterium acnes: a 15 year bacteriological study and retrospective evaluation. J Dermatol 15: 149–154
Lehmann L, Becker A, Gloor M (1998a) Lokalantibiotika in der Ulkustherapie. Therapeutische Empfehlungen auf der Basis der aktuellen Resistenzsituation. Phlebologie 27: 25–31
Lehmann L, Clemens M, Gloor M, Fluhr JW (1998b) Über die Effektivität von Tretinoin in Lokaltherapeutika - Lösungs-versus Suspensionszubereitungen - Wechselwirkungen mit Erythromycin. Akt Dermatol 24: 51–55
Leung DYM, Haub P, Strickland I, Travers JB, Norris DA (1998) The role of superantigens in human diseases: therapeutic implications for the treatment of skin diseases. Br J Dermatol 139 Suppl 53: 17–29
Leyden JJ, McGinley KJ, Cavalieri St, Webster GF, Mills OH, Kligman AM (1993) Propionibac-terium acnes resistance to antibiotics in acne patients J Am Acad Dermatol 8: 41–45
Mills OH, Kligman AM (1978) Treatment of acne vulgaris with topically applied erythromycin and tretinoin. Acta Derm Venereol (Stockh) 58: 555–557
Mills OH, Berger RS (1992) A double blind evaluation of tretinoin alone and in combination with erythromycin/benzoyl peroxide in acne vulgaris. Cutis 49: 12–15
Milstone EB, McDonald AJ, Scholhamer CF (1981) Pseudomembraneous colitis after topical application of clindamycin. Arch Dermatol 117: 154–155
Monographie Chloramphenicol (1994) BAnz 46: 9128
Monographie Gentamycin (1994) BAnz 46: 7359
Monographie Polymycin B (1994) BAnz 46: 9236
Monti G, Tonetto P, Mostert M, Oggero R (1996) Staphylococcus aureus skin colonization in infants with atopic dermatitis. Dermatology 193: 83–87
Niedner R (1992) Antibiotika. In: Niedner R, Ziegenmeyer J (Hrsg) Dermatika - Therapeutischer Einsatz, Pharmakologie und Pharmazie, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S 88–99
Nishijima S, Akamatsu H, Kurokawa I, Asada Y (1994) The antibiotic susceptibility of propionibacterium acnes and staphylococcus epidermidis isolated from acne. J Dermatol 21: 166–171
Packman AM, Brown RH, Dunlap FE, Kraus SJ, Webster GF (1996) Treatment of acne vulgaris: combination of 3% erythromycin and 5% benzoyl peroxide in a gel compared to clindamycin. Int J Dermatol 35: 209–211
Parry MF, Rha CK (1986) Pseudomembraneous colitis caused by topical clindamycin phosphate. Arch Dermatol 122: 583–584
Puschmann M, Meyer-Rohn J (1982) The efficacy of a topical preparation containing erythromycin in the treatment of acne. Dermatologica 164: 343-349
Rietschel R, Duncan BS (1983) Clindamycin phosphate used in combination with tretinoin in the treatment of acne. Int J Dermatol 22: 41–43
Sawchuk RJ, Rector TS (1980) Drug kinetics in burn patients. Clin Pharmacokin 5: 548–556
Simon S, Stille W (1994) Antibiotika Therapie in Klinik und Praxis, 8. Aufl., Schattauer, Stuttgart New York
Stoughton RB (1970) Bioassay of antimicrobials - a method for measuring penetration of agents into human skin. Arch Derm 101: 160–167
Stüttgen G, Täubner U, Bauer E, Zesch A (1986) Die lokale und transcutane Pharmakotherapie. Hautarzt 37: 65–76
Thong UH, Ferrante A (1979) Inhibition of mitogen induced human lymphocyte proliferation responses by tetracycline analogs. Clin Exp Immunol 35: 443–446
Toyoda M, Morohashi M (1998) An overview of topical antibiotics for acne treatment. Dermatology 196: 130–134
Tucker SB, Tausend R, Cochran R, Flannigan SA (1984) Comparison of topical clindamycin phosphate, benzoyl peroxide, and a combination of the two for the treatment of acne vulgaris. Br J Dermatol 110: 487–492
Webster GF, McGinley KJ, Leyden JJ (1981) Inhibition of lipase production in propionibacterium acnes by subminimal inhibitory concentrations of tetracycline and erythromycin. Br J Dermatol 104: 453–457
Wechsler HL, Kirk J, Slone J (1978) Acne treated with a topical tetracycline preparation: results of a one year multi-group study. Int J Dermatol 17: 237–242
Williams JV, Vowels BR, Honig PH, Leyden JJ (1998) S. aureus isolation from the lesions, the hands, and the anterior nares of patients with atopic dermatitis. Pediatric Dermatol 15: 194–198
Zesch A (1986) Short and long term risks of topical drugs. Br J Dermatol 115 Suppl 31: 63–70
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Gloor, M. (2000). Antibiotika. In: Dermatologische Externatherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-58308-7_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-58308-7_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63533-5
Online ISBN: 978-3-642-58308-7
eBook Packages: Springer Book Archive